Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management
Open accessThe DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Abstract
Patients with inflammatory bowel diseases (IBDs), such as ulcerative colitis and Crohn’s disease, have an increased risk of developing colorectal cancer (CRC). Although advancements in endoscopic imaging techniques, integrated surveillance programs, and improved medical therapies have contributed to a decreased incidence of CRC in patients with IBD, the rate of CRC remains higher in patients with IBD than in individuals without chronic colitis. Patients with IBD-related CRCs exhibit a poorer prognosis than those with sporadic CRCs, owing to their aggressive histological characteristics and lower curative resection rate. In this review, we present an updated overview of the epidemiology, etiology, risk factors, surveillance strategies, treatment recommendations, and prognosis of IBD-related CRCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Colonoscopy is the optimal strategy for the prevention of CRC in patients with IBD[44].”
From Risk factors, prevention and screening of colorectal cancer: A rising problem (2025) · cites this paper as [44]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959 · cited 2×
“2%, with cumulative risks of 2%, 8%, and 18% at 10, 20, and 30 years, respectively [13].”
BackgroundLamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910 · cited 1×
“Recently, several new endoscopic techniques have emerged to identify dysplastic or cancerous lesions [8,9].”
BackgroundMaaser, C., Sturm, A., Vavricka, S. R., Kucharzik, T., Fiorino, G., Annese, V., Calabrese, E., Baumgart, D. C., Bettenworth, D., Borralho Nunes, P., et al. (2019) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjy113 · Cited by 1,823 · cited 1×
“BSG 2019 [46] HD-WLE rather than SD-WLE SD or HD-WLE with DCE”
MethodUlcerative Colitis and Colorectal Cancer: A Population-Based Study
Ekbom, A., Helmick, C., Zack, M., & Adami, H.-O. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231802 · Cited by 1,777 · cited 2×
“Patients with inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), have an increased risk of developing colorectal cancer (CRC) [1,2].”
BackgroundACG Clinical Guideline: Ulcerative Colitis in Adults
Rubin, D. T., Ananthakrishnan, A. N., Siegel, C. A., Sauer, B. G., & Long, M. D. (2019) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000152 · Cited by 1,577 · cited 5×
“ACG 2019 [8] SD colonoscopy with DCE HD-WLE with NBI or DCE”
BackgroundMethodInfluentialDignass, A., Lindsay, J. O., Sturm, A., Windsor, A., Colombel, J.-F., Allez, M., D'Haens, G., D'Hoore, A., Mantzaris, G., Novacek, G., et al. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.002 · Cited by 1,548
Itzkowitz, S. H., & Yio, X. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00079.2004 · Cited by 1,274 · cited 1×
“Chronic inflammation causes oxidative stress-induced injuries [22].”
Harbord, M., Eliakim, R., Bettenworth, D., Karmiris, K., Katsanos, K., Kopylov, U., Kucharzik, T., Molnár, T., Raine, T., Sebastian, S., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx009 · Cited by 1,180
Intestinal Inflammation and Cancer
Ullman, T. A., & Itzkowitz, S. H. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.057 · Cited by 1,119 · cited 1×
“However, unlike sporadic CRC, IBD-CRC does not follow the conventional adenoma–carcinoma sequence; instead, it can progress from low- to high-grade dysplasia (HGD) and ultimately to CRC [31].”
BackgroundColorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management
Shah, S. C., & Itzkowitz, S. H. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.10.035 · Cited by 838 · cited 4×
“However, when invisible dysplasia is detected through random biopsies, the appropriate strategies to discuss include intense surveillance, reassessment by IBD experts, or surgical resection based on patient factors (such as age, family history, and concomitant PSC) and disease factors (such as severity of dysplasia, i…”
BackgroundMethodInfluentialEvidence-based clinical practice guidelines for inflammatory bowel disease
Matsuoka, K., Kobayashi, T., Ueno, F., Matsui, T., Hirai, F., Inoue, N., Kato, J., Kobayashi, K., Kobayashi, K., Koganei, K., et al. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1439-1 · Cited by 698 · cited 1×
“According to the recent consensus guidelines, the BSG, the European Crohn’s and Colitis Organization (ECCO), and the Japanese Society of Gastroenterology (JSGE) have recommended the use of 5-ASA for chemoprevention [47,64,65].”
BackgroundCancers Complicating Inflammatory Bowel Disease
Beaugerie, L., & Itzkowitz, S. H. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403718 · Cited by 678 · cited 1×
“In the carcinogenic process in IBD-CRC, mutation and loss of the APC gene are less frequent and occur in a later phase of the dysplasia–carcinoma sequence, whereas mutation and loss of P53 are more frequent and likely to occur in an earlier phase [32].”
BackgroundThirty-Year Analysis of a Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis
Rutter, M. D., Saunders, B. P., Wilkinson, K. H., Rumbles, S., Schofield, G., Kamm, M. A., Williams, C. B., Price, A. B., Talbot, I. C., & Forbes, A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.035 · Cited by 650 · cited 1×
“UC diagnosis at a young age has been consistently associated with a greater risk of CRC than UC diagnosis at an older age [1], and longer disease duration has been reported to significantly increase the cumulative incidence of CRC [13,38,39].”
BackgroundJess, T., Gamborg, M., Matzen, P., Munkholm, P., & Sorensen, T. I. A. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00287.x · Cited by 586 · cited 1×
“The risk of CRC is significantly increased (by as much as two–three-fold) in patients with a long-standing history of UC and CD; however, the exact risk value may vary according to studies, time periods, and individual risk factors [3,12].”
BackgroundInflammation and colorectal cancer: colitis-associated neoplasia
Grivennikov, S. I. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-012-0352-6 · Cited by 551 · cited 1×
“In patients with chronic colitis, continuous stimulation of epithelial proliferation in an inflammatory process may lead to carcinogenesis [20,21].”
BackgroundFarraye, F. A., Odze, R. D., Eaden, J., & Itzkowitz, S. H. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.037 · Cited by 532 · cited 2×
“Total proctocolectomy with ileal pouch-anal anastomosis (IPAA) is the standard procedure for cases of HGD or CRC [59,67].”
BackgroundLutgens, M. W. M. D., van Oijen, M. G. H., van der Heijden, G. J. M. G., Vleggaar, F. P., Siersema, P. D., & Oldenburg, B. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31828029c0 · Cited by 528 · cited 2×
“The risk of CRC is significantly increased (by as much as two–three-fold) in patients with a long-standing history of UC and CD; however, the exact risk value may vary according to studies, time periods, and individual risk factors [3,12].”
BackgroundEvidence-based clinical practice guidelines for inflammatory bowel disease 2020
Nakase, H., Uchino, M., Shinzaki, S., Matsuura, M., Matsuoka, K., Kobayashi, T., Saruta, M., Hirai, F., Hata, K., Hiraoka, S., et al. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01784-1 · Cited by 505
Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study
Olén, O., Erichsen, R., Sachs, M. C., Pedersen, L., Halfvarson, J., Askling, J., Ekbom, A., Sørensen, H. T., & Ludvigsson, J. F. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32545-0 · Cited by 470 · cited 1×
“38 per 1000 py in reference individuals during the same period [18].”
BackgroundKamiński, M., Hassan, C., Bisschops, R., Pohl, J., Pellisé, M., Dekker, E., Ignjatovic-Wilson, A., Hoffman, A., Longcroft-Wheaton, G., Heresbach, D., et al. (2014) · Endoscopy · doi:10.1055/s-0034-1365348 · Cited by 433
Laine, L., Kaltenbach, T., Barkun, A., McQuaid, K. R., Subramanian, V., Soetikno, R., East, J. E., Farraye, F. A., Feagan, B., Ioannidis, J., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.12.009 · Cited by 415
ECCO-ESCP Consensus on Surgery for Crohn’s Disease
Bemelman, W. A., Warusavitarne, J., Sampietro, G. M., Serclova, Z., Zmora, O., Luglio, G., de Buck van Overstraeten, A., Burke, J. P., Buskens, C. J., Francesco, C., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx061 · Cited by 399
European evidence based consensus on surgery for ulcerative colitis
Øresland, T., Bemelman, W. A., Sampietro, G. M., Spinelli, A., Windsor, A., Ferrante, M., Marteau, P., Zmora, O., Kotze, P. G., Espin-Basany, E., et al. (2015) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2014.08.012 · Cited by 353 · cited 6×
“A concurrent diagnosis of primary sclerosing cholangitis (PSC) is one of the well-known risk factors for IBD-CRC [42].”
BackgroundInfluentialBisschops, R., East, J. E., Hassan, C., Hazewinkel, Y., Kamiński, M. F., Neumann, H., Pellisé, M., Antonelli, G., Bustamante Balen, M., Coron, E., et al. (2019) · Endoscopy · doi:10.1055/a-1031-7657 · Cited by 340 · cited 1×
“Several international societies provide guidance on techniques for surveillance colonoscopy (Table 2) [8,38,47,51,52].”
BackgroundChoi, C.-H. R., Rutter, M. D., Askari, A., Lee, G. H., Warusavitarne, J., Moorghen, M., Thomas-Gibson, S., Saunders, B. P., Graham, T. A., & Hart, A. L. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.65 · Cited by 295 · cited 1×
“As mentioned above, the incidence of IBD-CRC seems to decrease over time, likely due to improved medical therapies for inflammation management and endoscopic screening and surveillance [16,17].”
BackgroundCurrent management of inflammatory bowel disease and colorectal cancer.
Mattar, M. C., Lough, D., Pishvaian, M. J., & Charabaty, A. (2011) · Europe PMC (PubMed Central) · Cited by 285
Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease−Associated Colorectal Cancers
Robles, A. I., Traverso, G., Zhang, M., Roberts, N. J., Khan, M. A., Joseph, C., Lauwers, G. Y., Selaru, F. M., Popoli, M., Pittman, M. E., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.036 · Cited by 276
Systematic review with meta‐analysis: the declining risk of colorectal cancer in ulcerative colitis
Castaño‐Milla, C., Chaparro, M., & Gisbert, J. P. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12651 · Cited by 268
Murthy, S. K., Feuerstein, J. D., Nguyen, G. C., & Velayos, F. S. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.05.063 · Cited by 267 · cited 5×
“UC diagnosis at a young age has been consistently associated with a greater risk of CRC than UC diagnosis at an older age [1], and longer disease duration has been reported to significantly increase the cumulative incidence of CRC [13,38,39].”
BackgroundInfluentialJess, T., Horváth-Puhó, E., Fallingborg, J., Rasmussen, H. H., & Jacobsen, B. A. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.249 · Cited by 243 · cited 1×
“As mentioned above, the incidence of IBD-CRC seems to decrease over time, likely due to improved medical therapies for inflammation management and endoscopic screening and surveillance [16,17].”
BackgroundWijnands, A. M., de Jong, M. E., Lutgens, M. W. M. D., Hoentjen, F., Elias, S. G., & Oldenburg, B. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.036 · Cited by 240
Familial predisposition for colorectal cancer in chronic ulcerative colitis: A case-control study
NUAKO, K., AHLQUIST, D., MAHONEY, D., SCHAID, D., SIEMS, D., & LINDOR, N. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70077-0 · Cited by 234 · cited 1×
“Having a family history of IBD-CRC also significantly affects the incidence, with a two-fold higher risk of CRC in patients with first-degree CRC relatives than in those without first-degree CRC relatives [40].”
BackgroundGenetic and epigenetic characteristics of inflammatory bowel disease-associated colorectal cancer
Rajamäki, K., Taira, A., Katainen, R., Välimäki, N., Kuosmanen, A., Plaketti, R.-M., Seppälä, T. T., Ahtiainen, M., Wirta, E.-V., Vartiainen, E., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.04.042 · Cited by 230
Watanabe, T., Konishi, T., Kishimoto, J., Kotake, K., Muto, T., & Sugihara, K. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21365 · Cited by 217 · cited 1×
“Several distinct characteristics of IBD-CRC may contribute to this difference in prognosis, such as younger age at diagnosis, emergency presentation or diagnosis as an emergency, an increased likelihood of right-sided colon involvement [4], and histological features like multifocal tumors, poor/undifferentiated histol…”
BackgroundYaeger, R., Shah, M. A., Miller, V. A., Kelsen, J. R., Wang, K., Heins, Z. J., Ross, J. S., He, Y., Sanford, E., Yantiss, R. K., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.04.001 · Cited by 200
Choi, C.-H. R., Al Bakir, I., Ding, N.-S. (., Lee, G.-H., Askari, A., Warusavitarne, J., Moorghen, M., Humphries, A., Ignjatovic-Wilson, A., Thomas-Gibson, S., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-314190 · Cited by 197 · cited 1×
“The accumulation of these factors contributes to the inflammatory burden, which plays a critical role in the development of IBD-CRC [43].”
BackgroundComparison of outcomes after hand-sewn versus stapled ileal pouch-anal anastomosis in 3,109 patients
Kirat, H. T., Remzi, F. H., Kiran, R. P., & Fazio, V. W. (2009) · Surgery · doi:10.1016/j.surg.2009.06.041 · Cited by 165 · cited 1×
“Stapled anastomosis is technically simple and superior to hand-sewn in terms of fewer anastomotic complications, better bowel function, and improved quality of life [68].”
BackgroundInflammatory Bowel Disease Confers a Lower Risk of Colorectal Cancer to Females Than to Males
Söderlund, S., Granath, F., Broström, O., Karlén, P., Löfberg, R., Ekbom, A., & Askling, J. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.007 · Cited by 161
Subramanian, V., Ramappa, V., Telakis, E., Mannath, J., Jawhari, A. U., Hawkey, C. J., & Ragunath, K. (2013) · Inflammatory Bowel Diseases · doi:10.1002/ibd.23002 · Cited by 152 · cited 1×
“A retrospective analysis compared 160 colonoscopies with SD-WLE and 209 colonoscopies with HD-WLE and showed that the colonoscopies with HD-WLE improved the targeted detection of dysplastic lesions during periodic surveillance [53].”
MethodChromoendoscopy versus narrow band imaging in UC: a prospective randomised controlled trial
Bisschops, R., Bessissow, T., Joseph, J. A., Baert, F., Ferrante, M., Ballet, V., Willekens, H., Demedts, I., Geboes, K. J., Hertogh, G. D., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313213 · Cited by 147
Ananthakrishnan, A. N., Cagan, A., Cai, T., Gainer, V. S., Shaw, S. Y., Churchill, S., Karlson, E. W., Murphy, S. N., Kohane, I., & Liao, K. P. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.07.018 · Cited by 131
Hurlstone, D. P., Sanders, D. S., Atkinson, R., Hunter, M. D., McAlindon, M. E., Lobo, A., Cross, S. S., & Thomson, M. A. (2006) · Gut · doi:10.1136/gut.2006.106294 · Cited by 127 · cited 1×
“Advanced technologies during endoscopic surveillance programs provide valuable tools for diagnosing dysplastic and cancerous lesions [8–10], while new advanced techniques for endoscopic resection can also improve the prognosis of IBD-CRC [11].”
BackgroundQiu, X., Ma, J., Wang, K., & Zhang, H. (2017) · Oncotarget · doi:10.18632/oncotarget.13715 · Cited by 123 · cited 1×
“However, the effect was limited to patients with UC, not in those with CD [63].”
BackgroundShah, S. C., ten Hove, J. R., Castaneda, D., Palmela, C., Mooiweer, E., Colombel, J.-F., Harpaz, N., Ullman, T. A., van Bodegraven, A. A., Jansen, J. M., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.01.023 · Cited by 109 · cited 1×
“A concurrent diagnosis of primary sclerosing cholangitis (PSC) is one of the well-known risk factors for IBD-CRC [42].”
BackgroundSelinger, C. P., Andrews, J. M., Titman, A., Norton, I. D., Jones, D. B., McDonald, C., Barr, G. D., Selby, W. S., & Leong, R. W. L. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.05.017 · Cited by 104 · cited 1×
“A subsequent study implied that the risk of CRC was low, with cumulative risks of 1%, 3%, and 7% at 10, 20, and 30 years, respectively [14].”
BackgroundBye, W. A., Ma, C., Nguyen, T. M., Parker, C. E., Jairath, V., & East, J. E. (2018) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0354-7 · Cited by 102 · cited 1×
“A recent meta-analysis, conducted in 2018, highlighted the importance of appropriate surveillance [45].”
MethodSelvaggi, F., Pellino, G., Canonico, S., & Sciaudone, G. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000026 · Cited by 101 · cited 1×
“7) when mucosectomy was not indicated [69].”
Ran, Z., Wu, K., Matsuoka, K., Jeen, Y. T., Wei, S. C., Ahuja, V., Chen, M., Hu, P., Andoh, A., Kim, H. J., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15185 · Cited by 100 · cited 1×
“Several international societies provide guidance on techniques for surveillance colonoscopy (Table 2) [8,38,47,51,52].”
BackgroundColorectal Cancer in Ulcerative Colitis: Mechanisms, Surveillance and Chemoprevention
Li, W., Zhao, T., Wu, D., Li, J., Wang, M., Sun, Y., & Hou, S. (2022) · Current Oncology · doi:10.3390/curroncol29090479 · Cited by 100 · cited 2×
“For patients with both IBD and PSC, alterations in bile acid metabolism, intestinal/biliary microbiomes, and the systematic immune system are suggested as contributing factors for cancer development [36].”
BackgroundFlores, B., O’Connor, A., & Moss, A. C. (2017) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2017.07.028 · Cited by 99 · cited 1×
“In patients with UC, the presence of mucosal inflammation is associated with an increased risk of subsequently developing colorectal neoplasia than of achieving mucosal healing [19].”
BackgroundDerikx, L. A. A. P., Nissen, L. H. C., Smits, L. J. T., Shen, B., & Hoentjen, F. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.08.042 · Cited by 94
Birch, R. J., Burr, N. E., Subramanian, V., Tiernan, J. P., Hull, M. A., Finan, P. J., Rose, A., Rutter, M. D., Valori, R., Downing, A., et al. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001941 · Cited by 86 · cited 1×
“Several distinct characteristics of IBD-CRC may contribute to this difference in prognosis, such as younger age at diagnosis, emergency presentation or diagnosis as an emergency, an increased likelihood of right-sided colon involvement [4], and histological features like multifocal tumors, poor/undifferentiated histol…”
BackgroundFrick, A. P., Khare, V., Paul, G., Lang, M., Ferk, F., Knasmüller, S., Beer, A., Oberhuber, G., & Gasché, C. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0451 · Cited by 80 · cited 1×
“Inflammation-driven carcinogenesis is characterized by a gradual increase in the levels of molecular markers associated with oxidative damage and DNA double-strand breaks [23].”
BackgroundEl-Dallal, M., Chen, Y., Lin, Q., Rakowsky, S. T., Sattler, L., Foromera, J., Grossberg, L. B., Cheifetz, A. S., & Feuerstein, J. D. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa011 · Cited by 79
KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis
Du, L., Kim, J. J., Shen, J., Chen, B., & Dai, N. (2017) · Oncotarget · doi:10.18632/oncotarget.14549 · Cited by 73 · cited 1×
“Accordingly, P53 may play a more important role in the development of IBD-CRC [33].”
BackgroundAlexandersson, B. T., Hamad, Y., Andréasson, A., Rubio‐Terres, C., Ando, Y., Tanaka, K., Ichiya, T., Rezaie, R., & Schmidt, P. T. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.04.049 · Cited by 72
Lu, C., Schardey, J., Zhang, T., Crispin, A., Wirth, U., Karcz, K. W., Bazhin, A. V., Andrassy, J., Werner, J., & Kühn, F. (2021) · Annals of Surgery · doi:10.1097/sla.0000000000005339 · Cited by 72
Improving the quality of surveillance colonoscopy in inflammatory bowel disease
Iacucci, M., Cannatelli, R., Tontini, G. E., Panaccione, R., Danese, S., Fiorino, G., Matsumoto, T., Kochhar, G. S., Shen, B., Kießlich, R., et al. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30194-3 · Cited by 54 · cited 1×
“Nevertheless, ESD in patients with IBD can be challenging due to the presence of fibrosis and chronic inflammation [60].”
BackgroundOksanen, P., Karvonen, A., Huhtala, H., Aitola, P. T., Hyöty, M. K., Nieminen, I., Hemminki, H., & Collin, P. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.04.003 · Cited by 53
Fujiwara, I., Yashiro, M., Kubo, N., Maeda, K., & Hirakawa, K. (2008) · Diseases of the Colon & Rectum · doi:10.1007/s10350-008-9212-9 · Cited by 51
Fornaro, R., Caratto, M., Caratto, E., Caristo, G., Fornaro, F., Giovinazzo, D., Sticchi, C., Casaccia, M., & Andorno, E. (2016) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2016.02.002 · Cited by 50 · cited 1×
“IBD-CRC accounts for up to 15% of annual deaths in patients with IBD [75].”
BackgroundMohan, B. P., Khan, S. R., Chandan, S., Kassab, L. L., Ponnada, S., Asokkumar, R., Shen, B., Iacucci, M., & Navaneethan, U. (2020) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2020.06.048 · Cited by 48 · cited 1×
“performed a meta-analysis, including 18 studies with 1037 patients, and reported that the pooled risk (rate per 1000 py of follow-up) of CRC, HGD, and any lesion was 2 (95% CI, 0–3), 2 (95% CI, 1–3), and 43 (95% CI, 30–57), respectively [76].”
MethodLeowardi, C., Schneider, M.-L., Hinz, U., Harnoss, J. M., Tarantino, I., Lasitschka, F., Ulrich, A. B., Büchler, M. W., & Kadmon, M. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4915-3 · Cited by 46 · cited 1×
“Several distinct characteristics of IBD-CRC may contribute to this difference in prognosis, such as younger age at diagnosis, emergency presentation or diagnosis as an emergency, an increased likelihood of right-sided colon involvement [4], and histological features like multifocal tumors, poor/undifferentiated histol…”
BackgroundPredicting Colorectal Cancer Occurrence in IBD
Yalchin, M., Baker, A., Graham, T. A., & Hart, A. L. (2021) · Cancers · doi:10.3390/cancers13122908 · Cited by 46 · cited 1×
“In addition to the known molecular risk factors above, risk stratification and prediction of cancer progression can be improved by the novel molecular biomarkers using gene panels, transcriptomics, and clonal evolutionary dynamics [35].”
BackgroundManta, R., Zullo, A., Telesca, D. A., Castellani, D., Germani, U., Bonetti, L. R., Conigliaro, R. L., & Galloro, G. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa158 · Cited by 44 · cited 1×
“Thus, this study suggested that ESD is a feasible treatment option for resecting non-invasive dysplastic lesions in patients with UC [61].”
BackgroundHistopathological diagnosis of ulcerative colitis‐associated neoplasia
Kawachi, H. (2019) · Digestive Endoscopy · doi:10.1111/den.13387 · Cited by 39 · cited 2×
“ESGE guideline 2019 [49] HD endoscopy and DCE or VCE”
BackgroundMethodChemoprevention of colorectal cancer in ulcerative colitis: digging deep in current evidence
Bezzio, C., Festa, S., Saibeni, S., & Papi, C. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1292129 · Cited by 36 · cited 1×
“Therefore, KRAS and P53 mutations can be informative biomarkers of IBD-CRC, given the higher prevalence of these genetic alterations than that in non-dysplastic mucosa [34].”
BackgroundWan, J., Wang, X., Yang, Z. P., & Wu, K. (2019) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12714 · Cited by 34
Cottliar, A., Fundia, A. F., Boerr, L. A., Sambuelli, A. M., Negreira, S., Gil, A. H., Gomez, J. C., Chopita, N., Bernedo, A., & Slavutsky, I. R. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02315.x · Cited by 33
ten Hove, J. R., Bogaerts, J. M. K., Bak, M. T. J., Laclé, M. M., Meij, V., Derikx, L. A. A. P., Hoentjen, F., Mahmmod, N., van Tuyl, S. A., & Oldenburg, B. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy253 · Cited by 33
Bogach, J., Pond, G. R., Eskicioglu, C., Simunovic, M. R. I., & Seow, H. Y. (2021) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-021-04913-6 · Cited by 31
Ramsey, M. L., Krishna, S. G., Stanich, P. P., Husain, S., Levine, E. J., Conwell, D. L., Hinton, A. M., & Zhang, C. (2017) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2017.54 · Cited by 28 · cited 1×
“Therefore, the authors concluded that IBD could adversely affect outcomes after CRC surgery [74].”
BackgroundArray-based identification of common DNA methylation alterations in ulcerative colitis
Koizumi, K., Alonso, S., Miyaki, Y., Okada, S., Ogura, H., Shiiya, N., Konishi, F., Taya, T., Perucho, M., & Suzuki, K. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1283 · Cited by 26
Colorectal cancer screening and surveillance in patients with inflammatory bowel disease in 2021
Huguet, J. M., Barceló, L. F., Suárez, P., Sánchez, E. R., Prieto, J. D., García, V., & Sempere, J. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i5.502 · Cited by 26 · cited 3×
“Table 1 shows the recommended surveillance intervals after the initial colonoscopy, which are based on individual risk of CRC [38,44].”
BackgroundChemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease
Hsiao, S.-W., Yen, H., & Chen, Y. (2022) · Gut and Liver · doi:10.5009/gnl210479 · Cited by 23 · cited 3×
“Biologic agents such as tumor necrosis factor-α (TNF-α), nonsteroidal anti-inflammatory drugs (NSAIDs), or acetylsalicyclic acid have failed to demonstrate protective effects [62].”
BackgroundOptimising inflammatory bowel disease surveillance and dysplasia management—Where do we stand?
Bakir, I. A., Kabir, M., Yalchin, M., & Hart, A. L. (2022) · United European Gastroenterology Journal · doi:10.1002/ueg2.12330 · Cited by 17
Georganta, I., McIntosh, S. J., Boldovjáková, D., Parnaby, C. N., Watson, A., & Ramsay, G. (2023) · Techniques in Coloproctology · doi:10.1007/s10151-023-02762-w · Cited by 16
Clarke, K., Kang, M., Gorrepati, V. S., Stine, J. G., Tinsley, A., Williams, E., Moyer, M. T., & Coates, M. D. (2020) · International Journal of Colorectal Disease · doi:10.1007/s00384-020-03719-3 · Cited by 14
Microsatellite instability in long-standing ulcerative colitis
Løvig, T., Andersen, S. N., Clausen, O. P. F., & Rognum, T. O. (2006) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520601013747 · Cited by 13
Lin, V. A., Lohse, R., Madsen, M. T., Fransgaard, T., Remzi, F. H., & Gögenür, I. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-021-10759-8 · Cited by 13
Kuryba, A., Vallance, A. E., Boyle, J. M., Braun, M. S., Blake, H. A., van der Meulen, J., Fearnhead, N. S., & Walker, K. (2022) · Colorectal Disease · doi:10.1111/codi.16133 · Cited by 11
Cited by
Inflammatory Bowel Disease and Colorectal Cancer
Fanizza, J., Bencardino, S., Allocca, M., Furfaro, F., Zilli, A., Parigi, T. L., Fiorino, G., Peyrin‐Biroulet, L., Danese, S., & D’Amico, F. (2024) · Cancers · doi:10.3390/cancers16172943 · Cited by 63
“The risk of IBD-CRC is significantly elevated (by as much as two to three times) in patients with a history of UC and CD of at least 8 years long-standing, referred to as ‘long-standing’ [3].”
BackgroundInfluentialRisk factors, prevention and screening of colorectal cancer: A rising problem
Tsukanov, V. V., Vasyutin, A. V., & Tonkikh, J. L. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i5.98629 · Cited by 42
Diet-microbiome interactions in cancer
Abdeen, S. K., Mastandrea, I., Stinchcombe, N., Puschhof, J., & Elinav, E. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.03.013 · Cited by 36
Baas, F. S., Brusselaers, N., Nagtegaal, I. D., Engstrand, L. G., & Boleij, A. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.07.008 · Cited by 36
Antioxidant Role of Probiotics in Inflammation-Induced Colorectal Cancer
Hamamah, S., Lobiuc, A., & Covașă, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169026 · Cited by 36
“Inflammation is a significant risk factor for CRC development as those with inflammatory bowel disease (IBD) experience up to a three-fold increased incidence of the condition [65].”
Background
Metadata
- Authors
- Sato, Y., Tsujinaka, S., Miura, T., Kitamura, Y., Suzuki, H., & Shibata, C.
- Affiliations
- Tohoku Medical and Pharmaceutical University Hospital (JP)
- Corresponding author
- Tsujinaka, Shingo
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2023-08-17
- Volume
- 15
- Issue
- 16
- Pages
- 4154
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC10452690
- OpenAlex
- W4385949386
- Semantic Scholar
- 9923dd56bd14e9fa0eaa73626ab070fd6890f050
- Cited by
- 111
- References
- 82
- Citations by year
- 2026: 36 · 2025: 45 · 2024: 25 · 2023: 5
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- inflammatory bowel disease, colorectal cancer, ulcerative colitis, Crohn's disease, cancer surveillance, endoscopic surveillance, risk factors, prognosis, curative resection, histological characteristics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.